Related Experiment Video
Updated: Dec 28, 2025

Electrocardiogram Recordings in Anesthetized Mice using Lead II
Published on: June 20, 2020
The ketogenic diet and the QT interval.
Sivakumar Sudhakaran1, Laila Yazdani1, Kevin R Wheelan1
1Department of Internal Medicine, Baylor University Medical Center and Baylor Jack and Jane Hamilton Heart and Vascular HospitalDallasTexas.
Congenital Long QT syndrome can worsen with the ketogenic diet. Metabolic changes from this diet may trigger dangerous heart rhythms like torsades de pointes in affected individuals.
Area of Science:
- Cardiology
- Genetics
- Metabolic Disorders
Background:
- Long QT syndrome (LQTS) is a genetic disorder affecting heart repolarization.
- It increases the risk of fatal arrhythmias and sudden cardiac death.
- Congenital LQTS presents with a prolonged QT interval on electrocardiogram.
Observation:
- A case report details a patient with pre-existing congenital Long QT syndrome.
- The patient developed QT prolongation and torsades de pointes.
- These cardiac events were associated with metabolic alterations during ketogenic diet therapy.
Findings:
- The ketogenic diet, often used for epilepsy or weight loss, can induce significant metabolic shifts.
- Metabolic changes, such as electrolyte imbalances or altered substrate utilization, may precipitate arrhythmias in susceptible individuals.
- This case suggests a potential link between ketogenic diet-induced metabolic changes and the exacerbation of LQTS.
Implications:
- Clinicians should exercise caution when prescribing ketogenic diets to patients with congenital Long QT syndrome.
- Monitoring for QT interval changes and arrhythmias is crucial during ketogenic diet initiation in at-risk populations.
- Further research is needed to elucidate the precise mechanisms linking ketogenic diet metabolism to LQTS exacerbation.
More Related Videos
08:28Methods for ECG Evaluation of Indicators of Cardiac Risk, and Susceptibility to Aconitine-induced Arrhythmias in Rats Following Status Epilepticus
Published on: April 5, 2011
07:15Determining the Likelihood of Variant Pathogenicity Using Amino Acid-level Signal-to-Noise Analysis of Genetic Variation
Published on: January 16, 2019
Related Concept Videos
Antiepileptic Drugs: Potassium Channel Activators
Ezogabine has gained approval as an adjunctive treatment...
Antiarrhythmic Drugs: Class III Agents as Potassium Channel Blockers
Electrocardiogram
Three major waveforms are present in a typical ECG recording: the P wave, the QRS complex, and...
Antiarrhythmic Drugs: Class I Agents as Sodium Channel Blockers
Class 1A Antiarrhythmic Drugs: These drugs work by moderately blocking sodium channels,...
Pharmacokinetics: Drug–Drug Interactions
Antiepileptic Drugs: Calcium Channel Blockers
Calcium channel blockers exert their antiepileptic effects by targeting T-type calcium channels, which are integral to transmitting nerve signals in the central nervous system. These channels allow the passage of calcium ions, which are vital for neuronal communication. By inhibiting T-type calcium channels, calcium channel blockers effectively reduce the release of neurotransmitters and...